Her research focuses on how consumers incorporate government-regulated product labeling into their decision-making and has been written about in U.S. News and World Report, the Wall Street Journal, and Discover Magazine. Her TEDx Talk based on her work has garnered nearly 50,000 views, and her paper on sunscreen product usage among Millennials was recognized as one of the Journal of Consumer Affairs' top-downloaded articles. Her teaching awards include Oregon State University-Cascade's campus-wide Teaching Excellence Award, a top honor given to one professor annually.
Innovation adoption is challenging at both intra-organizational and interorganizational levels. Several decades of innovation adoption research have identified various barriers at both levels. Intra-organizational barriers are often related to the characteristics of the innovation, adopters, managers, environment, and ecosystem but can also include an incompatibility with an organization’s strategy, structural impediments, organizational resource constraints, a lack of fit of the innovation with an organizational culture and climate, decision making challenges, a lack of integration with an organization’s knowledge management, human resource management practices, dynamic capabilities, and active innovation resistance from customers. Interorganizational barriers include uncertainty with learning and implementation, the distributed nature of the innovation process, differences in production systems, disparities in regulatory systems, variation within local contexts, and the nature of embedded knowledge adopted in diverse organizational contexts. One of the key missing aspects in understanding innovation adoption is how extant practices within an organizational or interorganizational context enhance or hinder innovation adoption. Although the practices of innovation adoption emerge and evolve dynamically, existing research does not highlight fine-grained practices that lead to its success or failure. A practice lens focuses on people’s recurrent actions and helps to understand social life as an ongoing production that results from these actions. The durability of practices results from the reciprocal interactions between agents and structures that are embedded within daily routines. A practice lens allows us to study practices from three different perspectives. The first perspective, empirically explores how people act in organizational contexts. The second, a theoretical focus investigates the structure of organizational life. This perspective also delves into the relations between the actions that people take over time and in varying contexts. Finally, the third perspective which is a philosophical one focuses on how practices reproduce organizational reality. By focusing on the unfolding of constellations of everyday activities in relation to other practices within and across time and space, a practice lens hones in on everyday actions. Everyday actions are consequential in producing the structural contours of social life. A practice lens emphasizes what people do repeatedly and how those repetitive actions impact the social world. A practice theory lens also challenges the assumption that things are separable and independent. Instead, it focuses on relationality of mutual constitution to understand how one aspect of the issue creates another aspect. Relationality of mutual constitution is the notion that things such as identities, ideas, institutions, power, and material goods take on meaning only when they are enacted through practices instead of these being innate features of these things Focusing on duality forces us to address the assumptions that underlie the separation. A practice perspective on innovation adoption highlights the concepts of duality, dynamics, reciprocal interactions, relationality, and distributed agency to inform both the theory and practice of innovation adoption. Understanding these concepts enables a practice lens for successful adoption of innovations that impact organizational and societal outcomes, such as economic development, productivity enhancement, entrepreneurship, sustainability, equity, health, and other economic, social, and environmental changes.
Cercospora leaf spot is one of the critical foliar fungal diseases of jasmine, which causes considerable yield losses. There are no cultivars or germplasm accessions that are resistant to this infection and hence fungicide usage is the mainstay of management of this disease, which poses a hazard to the environment. Polyploidization is one of the key breeding methods in jasmine as newly obtained polyploids may have increased resistance/tolerance to diseases owing to altered metabolite production. In the present study, seventeen putative polyploids were obtained from Jasminum sambac Cv. Ramanathapuram Gundumalli by treating with the polyploidizing agent, colchicine. Among them, two mutant plants (generated from the wild parent following treatment with 0.25% colchicine) exhibited no symptoms for Cercospora leaf spot, whereas the control had the highest mean PDI (63.65%). Non-targeted metabolite profiling experiment indicated that couple of antifungal compounds (such as 1H-1,2,4-Triazole-1-ethanol, α-butyl-α-(2,4-dichlorophenyl) and Dasycarpidan-1-methanol, acetate (ester)) were present only in the two newly evolved mutants of J. sambac and absent in wild parent. Molecular docking results have shown that the compound Dasycarpidan-1-methanol, acetate (ester) binds effectively with two fungal proteins 7EUS and 7EUT, which are actively involved in biosynthesis of cercosporin (which is a photoactivated toxin that uses reactive oxygen species (ROS) in host cells and damage cell components such as membranes, proteins and lipids). Thus, this study enabled the development of a natural and eco-friendly method of evolving and characterizing novel lines in jasmine, which would have potential applications in flower industry.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.